Tag: PD-1 and PD-L1 inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PD-1 and PD-L1 inhibitors

Head and Neck Cancer Treatment Market size is set to grow by USD 7.12 billion from 2024 ...

Added to Collection on: 2024-07-11 15:50:17

Tags for this article:

Antineoplastic drugs
Cancer immunotherapy
Orphan drugs
Cancer
Checkpoint inhibitor
Targeted therapy
Cancer treatment
Pembrolizumab
Head and neck cancer
Immunotherapy
Atezolizumab
PD-1 and PD-L1 inhibitors

Click the tags to see associated articles and topics

View Article Details
Evolving Standards of Care in the Systemic Treatment of Metastatic Urothelial Cancer

Added to Collection on: 2024-07-14 16:18:05

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Transitional cell carcinoma
Atezolizumab
Enfortumab vedotin
Nivolumab
Avelumab
Bladder cancer
Checkpoint inhibitor
PD-1 and PD-L1 inhibitors
Cisplatin
Gemcitabine

Click the tags to see associated articles and topics

View Article Details
CatalYm Announces New Financing of $150M to Support Broad Phase 2b Development ...

Added to Collection on: 2024-07-16 14:33:48

Tags for this article:

Immune system
Cancer immunotherapy
Orphan drugs
Antineoplastic drugs
Checkpoint inhibitor
Nivolumab
Programmed cell death protein 1
Non-small-cell lung cancer
PD-1 and PD-L1 inhibitors
Cancer immunology
CatalYm

Click the tags to see associated articles and topics

View Article Details
Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Added to Collection on: 2024-07-23 20:07:13

Tags for this article:

Cemiplimab
Sanofi
Skin cancer
Immunotherapy
Cutaneous leishmaniasis
Cancer treatment
PD-1 and PD-L1 inhibitors
Cutaneous squamous-cell carcinoma

Click the tags to see associated articles and topics

View Article Details
Cancer Therapy and The Intestinal Microbiome - Forbes

Added to Collection on: 2024-07-23 19:52:01

Tags for this article:

Immune system
Clusters of differentiation
Cancer immunotherapy
PD-1 and PD-L1 inhibitors
PD-L1
Checkpoint inhibitor
Programmed cell death protein 1
PDCD1LG2
Immunotherapy
Immune checkpoint
Cancer treatment
Immunologic checkpoint

Click the tags to see associated articles and topics

View Article Details
Cold and hot tumors: from molecular mechanisms to targeted therapy - Nature

Added to Collection on: 2024-10-17 23:38:19

Tags for this article:

Immune system
Clusters of differentiation
T cells
Cancer immunotherapy
Orphan drugs
Checkpoint inhibitor
Programmed cell death protein 1
Ipilimumab
PD-1 and PD-L1 inhibitors
Tumor microenvironment
PD-L1
Nivolumab

Click the tags to see associated articles and topics

View Article Details
Immunotherapy and Immune-Related Adverse Events | MedPage Today

Added to Collection on: 2024-10-18 18:32:24

Tags for this article:

Cancer immunotherapy
PD-1 and PD-L1 inhibitors
Checkpoint inhibitor
Hypophysitis
Chemotherapy
Immunotherapy
Pneumonitis
Cancer
Bryan J. Schneider

Click the tags to see associated articles and topics

View Article Details
10 biotech companies to watch in 2025 - Labiotech.eu

Added to Collection on: 2024-12-16 14:29:24

Tags for this article:

Biotechnology
Applied genetics
Bioethics
Gene therapy
Molecular biology
Orphan drug
PD-1 and PD-L1 inhibitors
Vertex Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Checkpoint Inhibitor Shows High Success Rate in Advanced Skin Cancer

Added to Collection on: 2025-03-05 16:51:03

Tags for this article:

Lung cancer
Cancer
Gynaecological cancer
Infectious causes of cancer
Cemiplimab
Cutaneous squamous-cell carcinoma
Checkpoint inhibitor
Non-small-cell lung cancer
Regeneron Pharmaceuticals
Skin cancer
Squamous-cell carcinoma
PD-1 and PD-L1 inhibitors
Regeneron
Libtayo

Click the tags to see associated articles and topics

View Article Details
Sun Pharma Acquires Checkpoint Therapeutics for $355 Million

Added to Collection on: 2025-03-10 18:15:51

Tags for this article:

Carcinoma
Lung cancer
Cancer immunotherapy
Orphan drugs
Anatomical pathology
Cutaneous squamous-cell carcinoma
Cosibelimab
Squamous-cell carcinoma
CSCC
Immunotherapy
Skin cancer
PD-1 and PD-L1 inhibitors
Checkpoint Therapeutics
Sun Pharma

Click the tags to see associated articles and topics

View Article Details